Tadas Jucikas is the founder and CEO of Genus AI, a generative AI platform that produces tens of millions of product images, videos, audiences and ad copy each month for direct-to-consumer and e-commerce brands. He holds a PhD in computational neuroscience from the University of Cambridge, where he decoded the behavior of microscopic worms and published in Nature Methods and PNAS, then spent years applying AI to human behavior for UK government departments and companies like Uber, EDF Energy and Tesco. He co-founded Genus AI with his brother Viktoras, raised $11M in seed capital, and also serves as founding dean at Turing College.

Emilė Radytė is a Harvard- and Oxford-trained neuroscientist and the co-founder and CEO of Samphire Neuroscience, a London-based neurotech company building drug-free, hormone-free wearable devices for menstrual health. Her flagship product, Nettle, is a head-worn device using non-invasive transcranial direct current stimulation (tDCS) to target the neurological drivers of menstrual pain and mood symptoms. Named to the Forbes 30 Under 30 Healthcare list in 2024, she came up through emergency medicine at Harvard and a PhD in psychiatry and engineering at Oxford, and reframes conditions like PMS and PMDD as questions of brain circuitry rather than hormones alone.

Aurimas Griciūnas is a Lithuanian ML/AI engineer, founder of SwirlAI, and author of the SwirlAI Newsletter with 58,000+ Substack followers. A former CPO at neptune.ai (acquired by OpenAI), he now runs SwirlAI — an AI engineering education and consulting firm — and is a LinkedIn Top Voice in AI with 120,000+ followers. His newsletter covers AI engineering, LLMOps, RAG architectures, and agentic systems from a production-first, no-hype perspective.